PHASEPLUS Trademark

Trademark Overview

On Friday, October 11, 2024, a trademark application was filed for PHASEPLUS with the United States Patent and Trademark Office. The USPTO has given the PHASEPLUS trademark a serial number of 98797045. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Monday, April 21, 2025. This trademark is owned by BioAccel, LLC. The PHASEPLUS trademark is filed in the Insurance & Financial Services category with the following description:

Facilitating and arranging for the financing of bio-tech companies and emerging bio-tech companies conducting drug trials.
phaseplus

General Information

Serial Number98797045
Word MarkPHASEPLUS
Filing DateFriday, October 11, 2024
Status680 - APPROVED FOR PUBLICATION
Status DateMonday, April 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkPHASE PLUS
Goods and ServicesFacilitating and arranging for the financing of bio-tech companies and emerging bio-tech companies conducting drug trials.

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, October 11, 2024
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBioAccel, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressGrand Rapids, MI 49503

Trademark Events

Event DateEvent Description
Friday, October 11, 2024NEW APPLICATION ENTERED
Monday, April 14, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 15, 2025ASSIGNED TO EXAMINER
Monday, April 21, 2025APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

phaseplus tech companies drug trials conducting emerging arranging facilitating financing